Blogs, News, & Whitepapers

SugarCone Insights

A BRIEF REVIEW OF DRUG DEVELOPMENT TARGETING THE LTβ/LTβR PATHWAY

Paul Rennert 12/1/24 Paul Rennert 12/1/24

A BRIEF REVIEW OF DRUG DEVELOPMENT TARGETING THE LTβ/LTβR PATHWAY

Read More

Attacking Cancers Using Novel Methods of Targeted Protein Degradation

Paul Rennert 10/6/24 Paul Rennert 10/6/24

Attacking Cancers Using Novel Methods of Targeted Protein Degradation

Read More

4-1BB and the critical importance of local control

Paul Rennert 6/10/24 Paul Rennert 6/10/24

4-1BB and the critical importance of local control

Read More

Biotech strategies for an uncertain world

Paul Rennert 4/2/24 Paul Rennert 4/2/24

Biotech strategies for an uncertain world

Read More

Recent CAR-T clinical studies in glioma and glioblastoma patients

Paul Rennert 4/1/24 Paul Rennert 4/1/24

Recent CAR-T clinical studies in glioma and glioblastoma patients

Read More

PD-1 versus Car-T: stop making sense

Paul Rennert 4/13/23 Paul Rennert 4/13/23

PD-1 versus Car-T: stop making sense

It all begins with an idea.

Read More

Why aren’t we better at weighing results and making sound conclusions?

Paul Rennert 3/29/23 Paul Rennert 3/29/23

Why aren’t we better at weighing results and making sound conclusions?

Read More

Teaching immune cells how to kill

Paul Rennert 3/1/23 Paul Rennert 3/1/23

Teaching immune cells how to kill

Read More

New Horizons Across the Immunotherapy Landscape

Paul Rennert 2/15/23 Paul Rennert 2/15/23

New Horizons Across the Immunotherapy Landscape

Read More